Marlborough-based medical device manufacturer Hologic has been issued a warning letter from the U.S. Food and Drug Administration concerning its BioZorb Marker, a device originally recalled in March.
On Friday, the FDA warned against using Hologic Inc.’s (NASDAQ:HOLX) BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the ...
Zacks Investment Research on MSN
HOLX vs. SYK: Which medical device leader is a solid bet now?
The global medical device industry is characterized by rapid technological advances, innovations and scientific discoveries.
ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc.
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient ...
The Food and Drug Administration issued a warning letter to Hologic Inc. (NASDAQ:HOLX), citing violations in the manufacturing and reporting processes for its BioZorb product line. The letter, ...
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Medical device manufacturer Hologic is broadening its focus on women’s health as the Marlborough-based firm has signed a definitive agreement to acquire the California-based medical technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results